Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference44 articles.
1. Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development;Harari;Semin Radiat Oncol.,2002
2. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med.,2006
3. Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab;Bolke;Strahlenther Onkol.,2008
4. Severe cutaneous reaction during radiation therapy with concurrent cetuximab;Budach;N Engl J Med.,2007
5. Cetuximab is effective, but more toxic than reported in the Bonner trial [letter];Lord;Clin Oncol (R Coll Radiol).,2008
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Global hotspots and research trends of radiation-induced skin injury: a bibliometric analysis from 2004 to 2023;Frontiers in Oncology;2024-08-26
2. Chinese clinical practice guidelines for the prevention and treatment of radiation‐induced dermatitis;Precision Radiation Oncology;2023-09
3. EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects;Anais Brasileiros de Dermatologia;2023-07
4. Pathogenesis of Oral Toxicities Associated with Targeted Therapy and Immunotherapy;International Journal of Molecular Sciences;2023-05-03
5. Les radiodermites après procédures interventionnelles guidées par rayons X;Annales de Dermatologie et de Vénéréologie - FMC;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3